Royal Bank of Canada’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
1,811
+183
| +11% | +$25.2K | ﹤0.01% | 4659 |
|
|
2025
Q1 | $294K | Buy |
1,628
+964
| +145% | +$174K | ﹤0.01% | 4074 |
|
|
2024
Q4 | $104K | Sell |
664
-2,113
| -76% | -$331K | ﹤0.01% | 4857 |
|
|
2024
Q3 | $506K | Buy |
2,777
+376
| +16% | +$68.5K | ﹤0.01% | 3677 |
|
|
2024
Q2 | $440K | Buy |
2,401
+1,377
| +134% | +$252K | ﹤0.01% | 3758 |
|
|
2024
Q1 | $182K | Sell |
1,024
-10,303
| -91% | -$1.83M | ﹤0.01% | 4342 |
|
|
2023
Q4 | $1.41M | Buy |
11,327
+4,078
| +56% | +$506K | ﹤0.01% | 2921 |
|
|
2023
Q3 | $841K | Buy |
7,249
+5,677
| +361% | +$659K | ﹤0.01% | 3131 |
|
|
2023
Q2 | $183K | Buy |
1,572
+276
| +21% | +$32.1K | ﹤0.01% | 4406 |
|
|
2023
Q1 | $104K | Sell |
1,296
-1,762
| -58% | -$141K | ﹤0.01% | 4777 |
|
|
2022
Q4 | $243K | Buy |
3,058
+2,640
| +632% | +$210K | ﹤0.01% | 4256 |
|
|
2022
Q3 | $29K | Buy |
418
+129
| +45% | +$8.95K | ﹤0.01% | 5505 |
|
|
2022
Q2 | $19K | Sell |
289
-1,243
| -81% | -$81.7K | ﹤0.01% | 5666 |
|
|
2022
Q1 | $102K | Sell |
1,532
-2,036
| -57% | -$136K | ﹤0.01% | 5158 |
|
|
2021
Q4 | $249K | Buy |
3,568
+3,171
| +799% | +$221K | ﹤0.01% | 4598 |
|
|
2021
Q3 | $21K | Buy |
397
+307
| +341% | +$16.2K | ﹤0.01% | 6155 |
|
|
2021
Q2 | $6K | Sell |
90
-1,008
| -92% | -$67.2K | ﹤0.01% | 6518 |
|
|
2021
Q1 | $85K | Buy |
1,098
+801
| +270% | +$62K | ﹤0.01% | 5076 |
|
|
2020
Q4 | $18K | Buy |
297
+223
| +301% | +$13.5K | ﹤0.01% | 5557 |
|
|
2020
Q3 | $4K | Sell |
74
-12
| -14% | -$649 | ﹤0.01% | 5684 |
|
|
2020
Q2 | $3K | Buy |
86
+32
| +59% | +$1.12K | ﹤0.01% | 5706 |
|
|
2020
Q1 | $2K | Buy |
+54
| New | +$2K | ﹤0.01% | 5797 |
|
|
2018
Q4 | – | Sell |
-11
| Closed | – | – | 5959 |
|
|
2018
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 6178 |
|